<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Pritchard Humphries | Activity</title>
	<link>https://www.catswannabecats.com/members/goatgong1/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/goatgong1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Pritchard Humphries.</description>
	<lastBuildDate>Fri, 19 Jun 2026 15:42:02 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">562de475b430bcf040f7e13e4332d330</guid>
				<title>Pritchard Humphries posted an update: 168% and 21.529%). The pooled odd ratios comparing D-MMR to [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25853/</link>
				<pubDate>Mon, 09 Jun 2025 11:56:59 -0400</pubDate>

									<content:encoded><![CDATA[<p>168% and 21.529%). The pooled odd ratios comparing D-MMR to proficient MMR favored low-stage EC disease (1.565; 0.894 to 2.740), lymphovascular invasion (1.765; 1.293 to 2.409), and myometrial invasion &gt;50% (1.271; 0.871 to 1.853).</p>
<p> Almost one-quarter of EC patients present with D-MMR tumors. The majority has less aggressive endometrioid&hellip;<span class="activity-read-more" id="activity-read-more-25853"><a href="https://www.catswannabecats.com/activity/p/25853/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4cdcd633dc0738af275e3f3c1c918663</guid>
				<title>Pritchard Humphries posted an update: The average plasma volume treated was 22 L. Efficacy of the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23895/</link>
				<pubDate>Sun, 08 Jun 2025 10:50:52 -0400</pubDate>

									<content:encoded><![CDATA[<p>The average plasma volume treated was 22 L. Efficacy of the IA column in log titer reduction of anti-ABO titer was 4 logs after the first use, 3 logs after 1</p>
<p> reuse, and 1.5 logs after 2</p>
<p> reuse. 12 (75%) patients successfully reached the target IgG titer of ≤14 solely with column reuse. One patient received a single session of plasma e&hellip;<span class="activity-read-more" id="activity-read-more-23895"><a href="https://www.catswannabecats.com/activity/p/23895/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c00df0b09fe5d10e45e2103376982b02</guid>
				<title>Pritchard Humphries posted an update: 1%BW at 1 MeV, which may have diverse applications in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20153/</link>
				<pubDate>Thu, 05 Jun 2025 11:27:47 -0400</pubDate>

									<content:encoded><![CDATA[<p>1%BW at 1 MeV, which may have diverse applications in various fields.For a Si-based all-optical spatial terahertz modulator (STM), an enhanced modulation efficiency under low illumination density would be of great significance to exploit the competence of THz technology in real-world applications. We presented here an implementation of such a&hellip;<span class="activity-read-more" id="activity-read-more-20153"><a href="https://www.catswannabecats.com/activity/p/20153/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">65634c245f7e5d526c6e26ce8e4cac53</guid>
				<title>Pritchard Humphries posted an update: These findings suggest the potential of miRNA-4525 in serum [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18471/</link>
				<pubDate>Tue, 03 Jun 2025 13:51:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>These findings suggest the potential of miRNA-4525 in serum EVs as a novel biomarker for advanced RCC.</p>
<p> Matrix metalloproteinase-1 is responsible for extracellular matrix regulation, and its genetic role in colorectal cancer (CRC) is unclear. The aim of the study was to investigate the contribution of Matrix metalloproteinase-1 genotypes to CRC&hellip;<span class="activity-read-more" id="activity-read-more-18471"><a href="https://www.catswannabecats.com/activity/p/18471/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d364a6842d73c4d0495ef886c8cad99a</guid>
				<title>Pritchard Humphries posted an update: We applied barbed suture as a surrogate technique to close [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4056/</link>
				<pubDate>Sat, 31 May 2025 12:00:37 -0400</pubDate>

									<content:encoded><![CDATA[<p>We applied barbed suture as a surrogate technique to close the stump of cystic duct. In patient 1, a 67-year-old woman with severe heart failure and type 2 diabetes mellitus was diagnosed with grade III AC. Pathological diagnosis was gangrenous cholecystitis. In patient 2, a 68-year-old woman who was referred to our hospital after 15days of&hellip;<span class="activity-read-more" id="activity-read-more-4056"><a href="https://www.catswannabecats.com/activity/p/4056/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">aa4b6a8f4fc805855e93457819221847</guid>
				<title>Pritchard Humphries became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/3922/</link>
				<pubDate>Sat, 31 May 2025 11:43:54 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>